Cormorant Asset Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-75,920
Closed -$1.79M 86
2016
Q3
$1.79M Hold
75,920
0.2% 67
2016
Q2
$1.9M Buy
75,920
+920
+1% +$23K 0.27% 62
2016
Q1
$3.31M Hold
75,000
0.5% 48
2015
Q4
$4.09M Hold
75,000
0.49% 49
2015
Q3
$3.14M Hold
75,000
0.5% 49
2015
Q2
$3.9M Buy
+75,000
New +$3.9M 0.52% 47